Our academic collaborators’ seminal contributions push the field forward
Our constellation of renowned thinkers and partners
The right collaborators across pharma, biotech and nonprofit
The next generation of scientific leaders in cancer immunotherapy
Stories & Announcements
PICI in the News
From Bench to Fireside
Resources for Press
01
PICI Welcomes New Staff Members
02
PICI Members and Partners Featured at #CARTCR
03
Developing Next-Gen Scientific Leaders: The Parker Institute for Cancer Immunotherapy Awards up to $2.9 Million to Eight Early Career Investigators
Develop breakthrough immune therapies to turn all cancers into curable diseases faster
The driving force behind PICI’s research and operations
Join us. Change lives.
Parker Bridge Fellow
Cécile Alanio, MD, PhD
University of Pennsylvania
Parker Senior Fellow
Katelyn Byrne, PhD
Justin Eyquem, PhD
University of California, San Francisco
Parker Scholar
Zinaida Good, PhD
Stanford Medicine
Matthew Gubin, PhD
The University of Texas MD Anderson Cancer Center
Kenneth Hu, PhD
Alexander Huang, MD
Scott James, MD, PhD
Memorial Sloan Kettering Cancer Center
Tijana Martinov, PhD
Fred Hutchinson Cancer Research Center
Sierra McDonald, PhD candidate
Andrew Rech, PhD
Ansuman Satpathy, MD, PhD
Santosha Vardhana, MD, PhD
Roberta Zappasodi, PhD